ArticleESMO open2023

A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone.

J Pearson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.